Multi-compartment Nanoparticles for Targeted Drug Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current formulations for delivering anti-tumor agents like cis-platinum face challenges such as toxicity, resistance development, and instability, which limit their effectiveness and specificity in targeting tumor cells while minimizing harm to healthy cells.

Innovation Solution

The development of multi-compartment nanoparticles with a solid core surrounded by alternating layers of anionic and cationic lipids, formed from functional amphiphilic molecules, which encapsulate therapeutic agents, providing enhanced stability and controlled release.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If cis-platinum is used as an anti-tumor agent, then anti-tumor activity is achieved, but toxicity to healthy cells and resistance development occur

Engineering Contradiction:
Improveanti-tumor activityVSAvoidtoxicity to healthy cells
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The formulation divides the delivery system into multiple compartments: a hydrophobic core compartment containing cis-platinum and a hydrophilic shell compartment providing stabilization. This segmentation allows the therapeutic agent to be isolated from harmful interactions while maintaining its activity, and enables selective delivery to tumor cells through the amphiphilic interface.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The amphiphilic molecule acts as an intermediary between the hydrophobic cis-platinum core and the hydrophilic environment. Its dual nature allows it to stabilize the nanoparticle formulation while facilitating controlled release and cellular uptake, mediating the interaction between the therapeutic agent and the biological environment to reduce toxicity.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Speed

If therapeutic agents are delivered quickly inside tumor cells, then pharmacological activity is enhanced, but stability over time is compromised

Engineering Contradiction:
Improveintracellular delivery speedVSAvoidformulation stability
Core Design Contradiction:
SpeedVSStability of the object's composition

Solution Approach 1:

The formulation assigns different properties to different compartments: the hydrophobic core provides rapid release capability for quick intracellular delivery, while the hydrophilic shell provides temporal stability to maintain formulation integrity. The amphiphilic interface creates a localized region that enables both rapid penetration and sustained stability through its dual chemical nature.

Inventive Principle:
Principle #3Local quality

3Productivity

If multiple therapeutic agents are encapsulated in the same formulation, then simultaneous delivery to target is achieved, but formulation complexity increases

Engineering Contradiction:
Improvesimultaneous delivery efficiencyVSAvoidformulation complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The amphiphilic molecule serves multiple functions simultaneously: it stabilizes the nanoparticle structure, enables hydrophobic core formation, facilitates hydrophilic interaction, and controls release kinetics. This multi-functionality allows multiple therapeutic agents to be encapsulated in a unified formulation that maintains simplicity while achieving simultaneous delivery to the target.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These nanoparticles enable efficient and rapid intracellular delivery of anti-tumor agents, reducing toxicity to healthy cells and delaying resistance, while maintaining therapeutic activity over time.

Implementation Method 1

surrounded by at least two layers of lipids of different polarity formed from functional amphiphilic molecules or macromolecules

Methodology Applied
Scientific EffectSelf-assembly: Self-Assembly

Implementation Method 2

each lipid layer consists of at least one functional amphiphilic compound

Methodology Applied
Scientific EffectAmphiphilic interaction: Amphiphiles

Implementation Method 3

alternating layers of anionic and cationic lipids

Methodology Applied
Scientific EffectElectrostatic interaction: Electrostatics

Implementation Method 4

allowing intracellular delivery of effective and rapid therapeutic agents

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentEP2435031B1Functional amphiphilic molecule or macromolecule formulations with multiple compartments
Publication Date: 2015.09.16 UNIVERSITE DE BORDEAUX
  • EP2435031B1 patent drawingFigure 1
  • EP2435031B1 patent drawingFigure 2
  • EP2435031B1 patent drawingFigure 3A~3B

AI summary

The invention relates to novel functional amphiphilic molecule or macromolecule formulations with multiple compartments for transporting or targeting at least one therapeutic agent, in particular an antitumor agent, as well as to a method for preparing such formulations and to the use thereof.